StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.87−0.54 (-7.29%)

Close on Nov 18, 2026Market cap $622.17MP/E –Yield –

Verastem operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Verastem's operating income for the twelve months ending Jun 30, 2026 was -$159.80M. For fiscal 2025 it was -$170.13M. The highest annual figure on record is -$13.70M in fiscal 2011.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$170.13M–
FY2024Dec 31, 2024-$114.96M–
FY2023Dec 31, 2023-$92.08M–
FY2022Dec 31, 2022-$72.94M–
FY2021Dec 31, 2021-$61.41M–
FY2020Dec 31, 2020-$49.36M–
FY2019Dec 31, 2019-$132.34M–
FY2018Dec 31, 2018-$94.78M–
FY2017Dec 31, 2017-$67.80M–
FY2016Dec 31, 2016-$37.00M–
FY2015Dec 31, 2015-$58.20M–
FY2014Dec 31, 2014-$53.61M–
FY2013Dec 31, 2013-$41.40M–
FY2012Dec 31, 2012-$32.23M–
FY2011Dec 31, 2011-$13.70M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$32.71M–
Q1 FY2026Mar 31, 2026-$44.90M–
Q4 FY2025Dec 31, 2025-$41.48M–
Q3 FY2025Sep 30, 2025-$40.72M–
Q2 FY2025Jun 30, 2025-$43.76M–
Q1 FY2025Mar 31, 2025-$44.17M–
Q4 FY2024Dec 31, 2024-$31.59M–
Q1 FY2024Jun 30, 2024-$46.34M–
Q4 FY2023Dec 31, 2023-$31.14M–
Q3 FY2023Sep 30, 2023-$21.31M–
Q2 FY2023Jun 30, 2023-$20.29M–
Q1 FY2023Mar 31, 2023-$19.34M–
Q4 FY2022Dec 31, 2022-$16.85M–
Q3 FY2022Sep 30, 2022-$17.71M–
Q2 FY2022Jun 30, 2022-$21.40M–
Q1 FY2022Mar 31, 2022-$16.98M–
Q4 FY2021Dec 31, 2021-$16.51M–
Q3 FY2021Sep 30, 2021-$14.85M-198.9%
Q2 FY2021Jun 30, 2021-$15.94M–
Q1 FY2021Mar 31, 2021-$14.11M–
Q4 FY2020Dec 31, 2020-$16.75M–
Q3 FY2020Sep 30, 2020$15.02M–
Q2 FY2020Jun 30, 2020-$21.26M–
Q1 FY2020Mar 31, 2020-$26.36M–
Q4 FY2019Dec 31, 2019-$33.29M–
Q3 FY2019Sep 30, 2019-$26.10M–
Q2 FY2019Jun 30, 2019-$38.28M–
Q1 FY2019Mar 31, 2019-$34.67M–
Q4 FY2018Dec 31, 2018-$34.26M–
Q3 FY2018Sep 30, 2018-$21.57M–
Q2 FY2018Jun 30, 2018-$18.19M–
Q1 FY2018Mar 31, 2018-$20.76M–
Q4 FY2017Dec 31, 2017-$18.05M–
Q3 FY2017Sep 30, 2017-$23.14M–
Q2 FY2017Jun 30, 2017-$13.47M–
Q1 FY2017Mar 31, 2017-$13.15M–
Q4 FY2016Dec 31, 2016-$11.80M–
Q3 FY2016Sep 30, 2016-$8.06M–
Q2 FY2016Jun 30, 2016-$8.71M–

More Verastem figures

See a number that looks wrong?